13F-HR filed by Ikarian Capital, LLC
Ikarian Capital, LLC filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 21:15:17 UTC, with 172 holding rows worth $994,154,406.
- Accession
- 0001420506-26-002881
- Filer
- CIK 1778253
- Filed
- 2026-11-16
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
13F report for Q3 2026
A holdings report, 172 entries on the cover page, a total value of $994,154,406 stated on the cover page (in dollars after the unit check, H1), rows summing to $994,154,406 with VALUE read as dollars as filed, 13F file number 028-19721. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| MODERNA INC | 60770K107 | COM | 400,000 | $77,028,000 | dollars as filed | put |
| Bristol-Myers Squibb Company | 110122108 | COM | 992,500 | $61,932,000 | dollars as filed | put |
| KODIAK SCIENCES INC | 50015M109 | COM | 533,113 | $50,539,113 | dollars as filed | |
| SPDR SER TR | 78464A870 | S&P BIOTECH | 300,000 | $47,304,000 | dollars as filed | put |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 99,800 | $29,064,754 | dollars as filed | call |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 285,909 | $28,441,484 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 389,100 | $25,470,486 | dollars as filed | put |
| VAXCYTE INC COM | 92243G108 | Stock | 400,465 | $22,786,459 | dollars as filed | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 734,559 | $18,973,659 | dollars as filed | |
| INCYTE CORP COM | 45337C102 | Stock | 150,000 | $18,202,500 | dollars as filed | put |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 850,000 | $17,127,500 | dollars as filed | call |
| VAXCYTE INC COM | 92243G108 | Stock | 300,000 | $17,070,000 | dollars as filed | put |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 518,500 | $16,804,586 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 561,459 | $16,338,456 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 502,372 | $15,935,239 | dollars as filed | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 133,100 | $14,879,249 | dollars as filed | put |
| KODIAK SCIENCES INC | 50015M109 | COM | 149,600 | $14,182,080 | dollars as filed | call |
| DISC MEDICINE INC COM | 254604101 | Stock | 200,000 | $13,092,000 | dollars as filed | call |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 400,000 | $12,916,000 | dollars as filed | |
| ALTO NEUROSCIENCE INC COM SHS | 02157Q109 | Stock | 482,338 | $12,314,089 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 370,084 | $11,850,090 | dollars as filed | |
| SUMMIT THERAPEUTICS INC | 86627T108 | COM | 650,000 | $10,991,500 | dollars as filed | call |
| ANI PHARMACEUTICALS INC | 00182C103 | COM | 149,065 | $10,829,573 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 232,055 | $10,637,402 | dollars as filed | |
| RAPPORT THERAPEUTICS INC COM | 75383L102 | Stock | 316,400 | $10,631,040 | dollars as filed | put |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 100,000 | $9,902,000 | dollars as filed | call |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 400,000 | $9,728,000 | dollars as filed | put |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 400,000 | $9,728,000 | dollars as filed | call |
| MAZE THERAPEUTICS INC COM | 578784100 | Stock | 301,402 | $8,192,106 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 251,500 | $8,151,115 | dollars as filed | put |
| CONTINEUM THERAPEUTICS INC CL A | 21217B100 | Stock | 594,666 | $7,980,417 | dollars as filed | |
| CUE BIOPHARMA INC | 22978P205 | COM | 290,633 | $7,518,676 | dollars as filed | |
| EUPRAXIA PHARMACEUTICALS INC | 29842P105 | COM 298736 AL 3 EURONET WORLDWIDE INC NOTE 0.750% 3/1 | 809,741 | $7,368,643 | dollars as filed | |
| TECTONIC THERAPEUTIC INC | 878972108 | COMMON STOCK | 306,338 | $7,134,612 | dollars as filed | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 350,000 | $7,052,500 | dollars as filed | put |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 522,765 | $7,041,645 | dollars as filed | |
| MONOPAR THERAPEUTICS INC | 61023L207 | COMMON STOCK | 86,761 | $6,912,250 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 267,000 | $6,450,720 | dollars as filed | call |
| C4 THERAPEUTICS INC | 12529R107 | COM STK | 1,933,000 | $6,436,890 | dollars as filed | |
| ALPHA COGNITION INC | 02074J501 | COM NEW | 701,259 | $6,311,331 | dollars as filed | |
| CYBIN INC | 23256X407 | COM NEW | 500,000 | $6,145,000 | dollars as filed | call |
| IMMUNOME INC | 45257U108 | COM | 285,000 | $6,130,351 | dollars as filed | |
| JADE BIOSCIENCES INC | 008064206 | COM NEW | 427,349 | $6,004,253 | dollars as filed | |
| CYBIN INC | 23256X407 | COM NEW | 487,575 | $5,992,297 | dollars as filed | |
| FAETH THERAPEUTICS INC | 81728A207 | COM NEW | 199,694 | $5,938,899 | dollars as filed | |
| DAMORA THERAPEUTICS INC | G2646Y104 | COMM STK | 275,710 | $5,867,108 | dollars as filed | |
| FREENOME INC | 35661P100 | COMMON STOCK | 362,626 | $5,711,360 | dollars as filed | |
| PROQR THERAPEUTICS NV | N71542109 | SHS EURO | 3,425,930 | $5,687,045 | dollars as filed | |
| RAPPORT THERAPEUTICS INC COM | 75383L102 | Stock | 166,400 | $5,591,040 | dollars as filed | call |
| CARDIOL THERAPEUTICS INC | 14161Y200 | COM CL A | 3,325,000 | $5,519,500 | dollars as filed | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 1,448,359 | $5,460,313 | dollars as filed | |
| PELTHOS THERAPEUTICS INC | 171126204 | COM SHS | 256,598 | $5,391,124 | dollars as filed | |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 2,119,704 | $5,278,064 | dollars as filed | |
| SEPTERNA INC COM | 81734D104 | Stock | 127,200 | $4,977,336 | dollars as filed | call |
| SPRUCE BIOSCIENCES INC | 85209E208 | COM NEW | 101,356 | $4,923,874 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 300,000 | $4,833,000 | dollars as filed | put |
| VOR BIOPHARMA INC | 929033207 | COMMON STOCK | 250,000 | $4,770,000 | dollars as filed | |
| VOGENX INC | 92859A106 | COM | 208,836 | $4,759,372 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 225,000 | $4,632,750 | dollars as filed | |
| BRIGHT MINDS BIOSCIENCES INC | 10919W405 | COMMON STOCK | 88,951 | $4,431,539 | dollars as filed | |
| CRESCENT BIOPHARMA INC | G2545C104 | COMMON STOCK | 300,000 | $4,377,000 | dollars as filed | call |
| SELLAS LIFE SCIENCES GROUP I | 81642T209 | COM NEW | 354,700 | $4,366,357 | dollars as filed | put |
| SURROZEN INC | 86889P208 | COMMON STOCK | 134,000 | $4,312,120 | dollars as filed | put |
| ZURA BIO LTD | G9TY5A101 | COMMON STOCK | 1,018,492 | $4,236,927 | dollars as filed | |
| INVENTIVA SA | 46124U107 | ADS | 1,129,101 | $4,215,200 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 300,000 | $4,041,000 | dollars as filed | call |
| CONTINEUM THERAPEUTICS INC CL A | 21217B100 | Stock | 300,000 | $4,026,000 | dollars as filed | call |
| CUMBERLAND PHARMACEUTICALS I | 230770109 | COM | 503,153 | $3,939,688 | dollars as filed | |
| SEPTERNA INC COM | 81734D104 | Stock | 100,047 | $3,914,839 | dollars as filed | |
| REZOLUTE INC | 76200L309 | COMMON STOCK | 935,012 | $3,870,950 | dollars as filed | |
| AMANAT ACQUISITION CORP | G0375M101 | CL A ORD | 349,836 | $3,725,753 | dollars as filed | |
| SEPTERNA INC COM | 81734D104 | Stock | 95,200 | $3,725,176 | dollars as filed | put |
| BICARA THERAPEUTICS INC | 055477103 | COM | 200,000 | $3,722,000 | dollars as filed | call |
| CAMP4 THERAPEUTICS CORP | 13463J101 | COM | 912,906 | $3,688,140 | dollars as filed | |
| OCUGEN INC | 67577C105 | COMMON STOCK | 3,562,972 | $3,669,861 | dollars as filed | |
| ALECTOR INC | 014442107 | COMMON STOCK | 1,982,606 | $3,667,822 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 250,000 | $3,665,000 | dollars as filed | put |
| ERASCA INC COM | 29479A108 | Stock | 250,000 | $3,665,000 | dollars as filed | call |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 383,281 | $3,311,547 | dollars as filed | |
| SILENCE THERAPEUTICS PLC | 82686Q101 | ADS | 821,790 | $3,287,160 | dollars as filed | |
| SURROZEN INC | 86889P208 | COMMON STOCK | 100,000 | $3,218,000 | dollars as filed | call |
| GINKGO BIOWORKS HOLDINGS INC | 37611X209 | COMMON STOCK | 250,000 | $3,207,500 | dollars as filed | |
| ATEA PHARMACEUTICALS INC | 04683R106 | COMMON STOCK | 614,500 | $3,201,545 | dollars as filed | call |
| QUINCE THERAPEUTICS INC COM | 22053A305 | Stock | 95,652 | $2,966,169 | dollars as filed | |
| Q32 BIO INC | 746964105 | Common Stock | 345,000 | $2,853,150 | dollars as filed | |
| ARVINAS INC | 04335A105 | COM | 358,257 | $2,771,118 | dollars as filed | |
| ALUMIS INC | 022307102 | COM | 356,300 | $2,633,057 | dollars as filed | call |
| CONNECT BIOPHARMA HLDGS LTD | G23549101 | SHS | 2,235,534 | $2,459,088 | dollars as filed | |
| REIN THERAPEUTICS INC | 00887A204 | COM NEW | 2,950,000 | $2,371,800 | dollars as filed | |
| KAZIA THERAPEUTICS LTD | 48669G303 | SPONSORED ADS | 246,201 | $2,362,298 | dollars as filed | |
| ACUMEN PHARMACEUTICALS INC | 00509G209 | CMN | 1,053,797 | $2,339,429 | dollars as filed | |
| INVIVYD INC | 00534A102 | COMMON STOCK | 2,656,570 | $2,311,482 | dollars as filed | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 112,000 | $2,256,800 | dollars as filed | |
| PROMIS NEUROSCIENCES INC | 74346M505 | COM SHS | 205,000 | $2,224,250 | dollars as filed | |
| CRESCENT BIOPHARMA INC | G2545C104 | COMMON STOCK | 150,061 | $2,189,391 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 142,500 | $2,184,525 | dollars as filed | call |
| Obsidian Therapeutics, Inc. | 67448A106 | Common Stock, $0.0001 par value per share | 158,942 | $2,182,274 | dollars as filed | |
| CAPRICOR THERAPEUTICS INC | 14070B309 | COMMON STOCK | 229,215 | $2,170,666 | dollars as filed | |
| DELCATH SYSTEMS INC | 24661P807 | COMMON STOCK | 135,667 | $2,166,602 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 250,000 | $2,160,000 | dollars as filed | call |
| 4D MOLECULAR THERAPEUTICS INC COM | 35104E100 | Stock | 150,037 | $2,147,029 | dollars as filed | |
| XENCOR INC | 98401F105 | COMMON STOCK | 84,700 | $2,113,265 | dollars as filed | put |
| XENCOR INC | 98401F105 | COMMON STOCK | 84,700 | $2,113,265 | dollars as filed | call |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 6,942 | $2,021,718 | dollars as filed | |
| NEURONETICS INC | 64131A105 | COM | 810,182 | $1,895,826 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 133,181 | $1,777,966 | dollars as filed | |
| LEXEO THERAPEUTICS INC | 52886X107 | COMMON STOCK | 513,011 | $1,733,977 | dollars as filed | |
| VERASTEM INC | 92337C203 | COMMON STOCK | 213,865 | $1,721,614 | dollars as filed | |
| JOURNEY MED CORP | 48115J109 | COM | 251,436 | $1,719,822 | dollars as filed | |
| IMMUNIC INC | 4525EP200 | COM NEW | 182,464 | $1,696,915 | dollars as filed | |
| PEPGEN INC COM | 713317105 | Stock | 693,539 | $1,678,365 | dollars as filed | |
| C4 THERAPEUTICS INC | 12529R107 | COM STK | 500,000 | $1,665,000 | dollars as filed | call |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 449,161 | $1,661,896 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 50,000 | $1,614,500 | dollars as filed | call |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 65,000 | $1,421,550 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 90,183 | $1,382,505 | dollars as filed | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 700,000 | $1,343,999 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 16,858 | $1,325,207 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 49,800 | $1,203,168 | dollars as filed | |
| INVENTIVA SA | 46124U107 | ADS | 315,600 | $1,164,564 | dollars as filed | call |
| PALATIN TECHNOLOGIES INC | 696077601 | COM NEW | 130,000 | $1,153,100 | dollars as filed | |
| IBIO INC | 451033708 | CMN | 957,062 | $1,129,333 | dollars as filed | |
| LIPOCINE INC NEW | 53630X203 | COM NEW | 508,556 | $1,118,824 | dollars as filed | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 1,000,000 | $1,080,000 | dollars as filed | |
| DBV TECHNOLOGIES S A | 23306J309 | SPONSORED ADS | 453,374 | $1,065,356 | dollars as filed | |
| HARROW INC | 415858109 | COM | 33,275 | $1,024,869 | dollars as filed | |
| QUOIN PHARMACEUTICALS LTD | 74907L409 | SPONSORED ADS | 211,538 | $964,613 | dollars as filed | |
| JASPER THERAPEUTICS INC | 471871202 | COM NEW | 1,342,626 | $778,723 | dollars as filed | |
| NEUMORA THERAPEUTICS INC. | 640979100 | COM | 1,278,408 | $762,187 | dollars as filed | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 220,400 | $720,708 | dollars as filed | put |
| CNS PHARMACEUTICALS INC | 18978H508 | COM | 135,830 | $719,900 | dollars as filed | |
| KALARIS THERAPEUTICS INC | 482929106 | COM | 248,257 | $717,462 | dollars as filed | |
| TENAX THERAPEUTICS INC | 88032L605 | COM NEW | 356,600 | $673,974 | dollars as filed | call |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 205,056 | $670,533 | dollars as filed | |
| AEON BIOPHARMA INC | 00791X209 | COM | 2,203,406 | $661,022 | dollars as filed | |
| TCGX ACQUISITION CORP | G8708J109 | COM | 50,000 | $625,501 | dollars as filed | |
| FRACTYL HEALTH INC | 35168W103 | COM | 1,100,000 | $598,839 | dollars as filed | |
| FOGHORN THERAPEUTICS INC | 344174107 | COMMON STOCK | 160,000 | $571,201 | dollars as filed | |
| Adlai Nortye | 00704R109 | SPONSORED ADS | 33,899 | $542,384 | dollars as filed | |
| PALISADE BIO INC | 696389402 | COMMON STOCK | 400,000 | $540,000 | dollars as filed | |
| EQUILLIUM INC | 29446K106 | COM | 303,555 | $493,277 | dollars as filed | |
| SIONNA THERAPEUTICS INC | 829401108 | COMMON STOCK | 85,300 | $448,678 | dollars as filed | |
| SIONNA THERAPEUTICS INC | 829401108 | COMMON STOCK | 85,300 | $448,678 | dollars as filed | put |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 28,700 | $431,361 | dollars as filed | call |
| IMMATICS N.V | N44445109 | SHS | 48,569 | $426,436 | dollars as filed | |
| LYELL IMMUNOPHARMA INC COM NEW | 55083R203 | Stock | 41,081 | $402,183 | dollars as filed | |
| ANTERIS TECHNOLOGIES GLOBAL | 03675P102 | COMMON STOCK | 50,862 | $395,198 | dollars as filed | |
| HYPERLIQUID STRATEGIES | 44916Y106 | COMMON STOCK | 30,001 | $368,112 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 9,717 | $316,774 | dollars as filed | |
| SOLID BIOSCIENCES INC | 83422E204 | COMMON STOCK | 42,956 | $310,572 | dollars as filed | |
| LEXICON PHARMACEUTICALS INC | 528872302 | COMMON STOCK | 164,674 | $308,763 | dollars as filed | |
| ALUMIS INC | 022307102 | COM | 41,177 | $304,298 | dollars as filed | |
| MACROGENICS INC | 556099109 | COM | 74,893 | $289,087 | dollars as filed | |
| TRAWS PHARMA INC | 68232V884 | COM NEW | 478,142 | $283,921 | dollars as filed | |
| SIONNA THERAPEUTICS INC | 829401108 | COMMON STOCK | 50,000 | $263,000 | dollars as filed | call |
| TENAX THERAPEUTICS INC | 88032L605 | COM NEW | 136,648 | $258,265 | dollars as filed | |
| EVAXION AS | 29970R303 | SPONSORED ADS | 74,698 | $245,010 | dollars as filed | |
| INMED PHARMACEUTICALS INC | 457637700 | COM NEW | 137,634 | $187,181 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 15,000 | $186,600 | dollars as filed | |
| NEUPHORIA THERAPEUTICS INC | 64136E102 | COM | 47,443 | $168,897 | dollars as filed | |
| VISTAGEN THERAPEUTICS INC | 92840H400 | COM | 519,077 | $159,772 | dollars as filed | |
| CARTESIAN THERAPEUTICS INC | 816212302 | COMMON STOCK | 20,807 | $150,018 | dollars as filed | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 89,136 | $148,856 | dollars as filed | |
| ENVERIC BIOSCIENCES INC | 29405E505 | COM SHS | 100,002 | $147,003 | dollars as filed | |
| VOYAGER THERAPEUTICS INC | 92915B106 | COMMON STOCK | 53,063 | $142,209 | dollars as filed | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 16,756 | $139,577 | dollars as filed | |
| NYXOAH S A | B6S7WD106 | SHS | 47,358 | $65,354 | dollars as filed | |
| CHEMOMAB THERAPEUTICS LTD | 16385C203 | SPONSORED ADS | 51,793 | $61,633 | dollars as filed | |
| MANGOCEUTICALS INC | 56270V205 | CMN | 138,146 | $59,140 | dollars as filed | |
| AIRSCULPT TECHNOLOGIES INC | 009496100 | COMMON STOCK | 16,398 | $28,861 | dollars as filed | |
| THERIVA BIOLOGICS INC | 87164U508 | COM NEW | 112,076 | $25,218 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 18,000 | $18,721 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-26-002881 | this filing | 2026-11-16 |